These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

52 related items for PubMed ID: 1316138

  • 1. Quinolone anti-infectives block cancer reproduction in animal tests.
    Oncology (Williston Park); 1992 Apr; 6(4):48. PubMed ID: 1316138
    [No Abstract] [Full Text] [Related]

  • 2. [New quinolones, current therapies].
    Auckenthaler R.
    Schweiz Rundsch Med Prax; 1988 Nov 08; 77(45):1217-8. PubMed ID: 2847274
    [No Abstract] [Full Text] [Related]

  • 3. Mode of action of new quinolones: the inhibitory activity on DNA gyrase.
    Sato K, Hoshino K, Mitsuhashi S.
    Prog Drug Res; 1992 Nov 08; 38():121-32. PubMed ID: 1319080
    [No Abstract] [Full Text] [Related]

  • 4. Structure-activity relationship of quinolone antibacterial agents: the effects of C-2 substitution.
    Chu DT, Lico IM, Claiborne AK, Plattner JJ, Pernet AG.
    Drugs Exp Clin Res; 1990 Nov 08; 16(5):215-24. PubMed ID: 1964116
    [Abstract] [Full Text] [Related]

  • 5. Analysis of eukaryotic topoisomerase II cleavage sites in the presence of the quinolone CP-115,953 reveals drug-dependent and -independent recognition elements.
    Spitzner JR, Chung IK, Gootz TD, McGuirk PR, Muller MT.
    Mol Pharmacol; 1995 Aug 08; 48(2):238-49. PubMed ID: 7651357
    [Abstract] [Full Text] [Related]

  • 6. [Quinolones. Gyrase inhibitors].
    Höffler D.
    Internist (Berl); 1994 May 08; 35(5):484-9. PubMed ID: 8021119
    [No Abstract] [Full Text] [Related]

  • 7. Update on cross-resistance of fluoroquinolones.
    Garau J.
    Int J Clin Pract Suppl; 2000 Dec 08; (115):94-8. PubMed ID: 11219309
    [No Abstract] [Full Text] [Related]

  • 8. Dual inhibition of DNA topoisomerases of Leishmania donovani by novel indolyl quinolines.
    Ray S, Sadhukhan PK, Mandal NB, Mahato SB, Majumder HK.
    Biochem Biophys Res Commun; 1997 Jan 03; 230(1):171-5. PubMed ID: 9020039
    [Abstract] [Full Text] [Related]

  • 9. Injured mitochondria in cells of Euglena gracilis after DNA gyrase inhibitors treatment.
    Polónyi J, Ebringer L, Krajcovic J, Kapeller K.
    Z Mikrosk Anat Forsch; 1990 Jan 03; 104(1):61-78. PubMed ID: 2161591
    [Abstract] [Full Text] [Related]

  • 10. Increased sensitivity to quinolone antibacterials can be engineered in human topoisomerase IIalpha by selective mutagenesis.
    Hammonds TR, Foster SR, Maxwell A.
    J Mol Biol; 2000 Jul 14; 300(3):481-91. PubMed ID: 10884345
    [Abstract] [Full Text] [Related]

  • 11. [Recent development in quinolone compounds antitumor quinolones].
    Yang YS, Zhao SR, Ji RY, Chen KX.
    Yao Xue Xue Bao; 1998 Jul 14; 33(2):157-60. PubMed ID: 11938953
    [No Abstract] [Full Text] [Related]

  • 12. Lycobetaine acts as a selective topoisomerase II beta poison and inhibits the growth of human tumour cells.
    Barthelmes HU, Niederberger E, Roth T, Schulte K, Tang WC, Boege F, Fiebig HH, Eisenbrand G, Marko D.
    Br J Cancer; 2001 Nov 16; 85(10):1585-91. PubMed ID: 11720449
    [Abstract] [Full Text] [Related]

  • 13. [Mechanism of action and resistance to fluoroquinolones].
    Alarcón T, López-Brea M.
    Enferm Infecc Microbiol Clin; 1996 Feb 16; 14(2):111-7. PubMed ID: 8714159
    [No Abstract] [Full Text] [Related]

  • 14. [How are quinolones used in clinical practice? Gyrase antagonists from the viewpoint of the hospital pharmacist].
    Schurz JK.
    Pharm Unserer Zeit; 2001 Feb 16; 30(5):400-5. PubMed ID: 11575176
    [No Abstract] [Full Text] [Related]

  • 15. [New quinoline chemotherapy. DNA gyrase inhibitors].
    Havlík J, Krcméry V.
    Cas Lek Cesk; 1986 Feb 14; 125(7):211-4. PubMed ID: 3006917
    [No Abstract] [Full Text] [Related]

  • 16. gyrB-225, a mutation of DNA gyrase that compensates for topoisomerase I deficiency: investigation of its low activity and quinolone hypersensitivity.
    Heddle JG, Lu T, Zhao X, Drlica K, Maxwell A.
    J Mol Biol; 2001 Jun 22; 309(5):1219-31. PubMed ID: 11399091
    [Abstract] [Full Text] [Related]

  • 17. [Where are quinolones going? New agents in development].
    Holzgrabe U.
    Pharm Unserer Zeit; 2001 Jun 22; 30(5):446-8. PubMed ID: 11575182
    [No Abstract] [Full Text] [Related]

  • 18. Fluoroquinolones.
    Molavi A.
    Am Fam Physician; 1988 May 22; 37(5):279-84. PubMed ID: 3284309
    [No Abstract] [Full Text] [Related]

  • 19. Molecular mechanisms of drug inhibition of DNA gyrase.
    Lewis RJ, Tsai FT, Wigley DB.
    Bioessays; 1996 Aug 22; 18(8):661-71. PubMed ID: 8760340
    [Abstract] [Full Text] [Related]

  • 20. [Gyrase inhibitor in pneumology. Ofloxacin--a new broad spectrum antibiotic in acute and chronic respiratory tract infections].
    Rubin AR.
    Prax Klin Pneumol; 1985 Oct 22; 39(10):360-1. PubMed ID: 2999748
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.